Search results
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 15 hours agoNovavax stock rocketed to a nearly two-year high in June, thanks to a $1.3 billion deal and the...
Novavax, With A 369% Gain, Reverses Bullish Gains After Key FDA Move
Investor's Business Daily· 1 week agoNovavax stock zipped higher Thursday — and then gave it all up — after the Food and Drug...
FDA Authorizes Updated Novavax COVID-19 Vaccine
Verywell Health via Yahoo News· 8 months agoNovavax's updated COVID-19 vaccine is now authorized for U.S. teens and adults. The protein-based vaccine is the only immunization option that does not...
FDA authorizes Novavax's Covid vaccine
NBC Universal via AOL· 2 years agoThe Food and Drug Administration on Wednesday authorized Novavax’s protein-based Covid vaccine for adults, providing Americans with an alternative to the...
Novavax (NVAX) Seeks FDA Authorization for COVID-19 Booster Dose
Zacks via Yahoo Finance· 2 years agoNovavax (NVAX) seeks label expansion from the FDA for its COVID-19 vaccine as a booster dose in...
Novavax (NVAX) Up 8% on FDA Nod for Updated COVID Booster Jab
Zacks via Yahoo Finance· 8 months agoNovavax's (NVAX) updated COVID vaccine is authorized under emergency use for individuals aged 12...
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks via Yahoo Finance· 1 month agoNovavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel...
The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
Zacks via Yahoo Finance· 4 weeks agoFor Immediate Release Chicago, IL – May 17, 2024 – Zacks.com announces the list of stocks featured...
Biotech Stock Roundup: BIIB, Eisai's Drug Update, NVAX Gains on Deal Amendment
Zacks via Yahoo Finance· 11 months agoIt was a busy week for the biotech sector, with many important regulatory and pipeline updates....
Novavax (NVAX) Beats on Q3 Earnings & Sales, Cuts Sales View
Zacks via Yahoo Finance· 7 months agoNovavax (NVAX) reports better-than-expected third-quarter results, with earnings and revenues...